1. Home
  2. GBIO vs CVU Comparison

GBIO vs CVU Comparison

Compare GBIO & CVU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • CVU
  • Stock Information
  • Founded
  • GBIO 2016
  • CVU 1980
  • Country
  • GBIO United States
  • CVU United States
  • Employees
  • GBIO N/A
  • CVU N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • CVU Military/Government/Technical
  • Sector
  • GBIO Health Care
  • CVU Industrials
  • Exchange
  • GBIO Nasdaq
  • CVU Nasdaq
  • Market Cap
  • GBIO 41.2M
  • CVU 44.5M
  • IPO Year
  • GBIO 2020
  • CVU N/A
  • Fundamental
  • Price
  • GBIO $5.19
  • CVU $2.24
  • Analyst Decision
  • GBIO Buy
  • CVU
  • Analyst Count
  • GBIO 4
  • CVU 0
  • Target Price
  • GBIO $10.67
  • CVU N/A
  • AVG Volume (30 Days)
  • GBIO 66.5K
  • CVU 6.0M
  • Earning Date
  • GBIO 11-07-2025
  • CVU 11-13-2025
  • Dividend Yield
  • GBIO N/A
  • CVU N/A
  • EPS Growth
  • GBIO N/A
  • CVU N/A
  • EPS
  • GBIO N/A
  • CVU N/A
  • Revenue
  • GBIO $21,230,000.00
  • CVU $71,767,103.00
  • Revenue This Year
  • GBIO N/A
  • CVU N/A
  • Revenue Next Year
  • GBIO N/A
  • CVU N/A
  • P/E Ratio
  • GBIO N/A
  • CVU N/A
  • Revenue Growth
  • GBIO 61.15
  • CVU N/A
  • 52 Week Low
  • GBIO $3.00
  • CVU $2.19
  • 52 Week High
  • GBIO $25.70
  • CVU $5.85
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 31.12
  • CVU 37.89
  • Support Level
  • GBIO $5.10
  • CVU $2.19
  • Resistance Level
  • GBIO $6.47
  • CVU $4.65
  • Average True Range (ATR)
  • GBIO 0.26
  • CVU 0.30
  • MACD
  • GBIO -0.14
  • CVU -0.02
  • Stochastic Oscillator
  • GBIO 6.57
  • CVU 2.03

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About CVU CPI Aerostructures Inc.

CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States. It also provides engineering, program management, supply chain management and kitting, and Maintenance Repair and Overhaul (MRO) services. CPI also acts as a subcontractor to prime aircraft manufacturers in the production of commercial aircraft parts. CPI Aero supplies the E-2D Advanced Hawkeye surveillance aircraft, the A-10 Thunderbolt attack jet, the Gulfstream G650, the UH-60 BLACK HAWK helicopter, and the S-92 helicopter, and others.

Share on Social Networks: